CT scans may predict best treatment for liver cancer patients
NCT ID NCT07449065
First seen Mar 11, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This study looked at 324 people with intermediate-stage liver cancer to see if CT scans could predict who would benefit from adding a targeted therapy pill to a standard procedure called TACE. The goal was to see if certain scan features could help doctors choose the best treatment. The study did not test a new treatment but aimed to improve how we select treatments for liver cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.